p53 264-272 (HLA-A*0201)
Single peptide LLGRNSFEV for stimulation of p53 (264-272)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Targeting diseases are cancer, allergies, viral infections and autoimmune disorders.
| Sequence: | LLGRNSFEV | |
| Gene: | TP53 | |
| Delivery: | 2-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Cellular tumor antigen p53 | |
| Species: | Human | |
| Allele: | HLA-A*02:01 | |
| Application : | Flow Cytometry | |
| Indication : | Cancer |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€60.40*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Product number:
EP05796_1